CSF monoamine metabolites in mania.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  American Journal of Psychiatry

• Publication date

  1983-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/AJP.140.4.396PMID 6188381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioural measurement and drug response characteristics of unipolar and bipolar depression

  1982cited by this paper
• Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment

  1982cited by this paper
• Regional Distribution and Production Rate of 3‐Methoxy‐4‐Hydroxyphenylethyleneglycol Sulphate (MHPG‐SO4) in Rat Brain

  1981cited by this paper
• Adrenoceptor regulation in rat brain: Chronic effects of α1- or α2-receptor blockers

  1981cited by this paper
• Biochemical evidence for simultaneous activation of multiple locus coeruleus efferents.

  1980cited by this paper
• Cerebrospinal fluid adrenaline and noradrenaline in depressed patients

  1980cited by this paper
• Biological component of the NIMH Clinical Research Branch Collaborative Program on the psychobiology of depression: I. Background and theoretical considerations

  1980cited by this paper
• Antimanic effect of clonidine.

  1980cited by this paper
• Biological component of the NIMH Clinical Research Branch Collaborative Program on the psychobiology of depression: II. Methodology and data analysis

  1980cited by this paper
• CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.

  1980cited by this paper
• Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.

  1979cited by this paper
• Evidence for a dopaminergic pathway in the rat descending from the A11 cell group to the spinal cord.

  1979cited by this paper
• Asymmetry and mood, emergent properties of serotonin regulation.

  1979cited by this paper
• Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems.

  1979cited by this paper
• Research diagnostic criteria: rationale and reliability.

  1978cited by this paper
• Cerebrospinal fluid norepinephrine in affective illness.

  1978cited by this paper
• A diagnostic interview: the schedule for affective disorders and schizophrenia.

  1978cited by this paper
• Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain

  1977cited by this paper
• Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient.

  1977cited by this paper
• A dopaminergic mechanism in mania.

  1976cited by this paper
• Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method

  1976cited by this paper
• LUMBAR CSF 5- HYDROXYINDOLEACETIC ACID AND HOMOVANILLIC ACID IN AFFECTIVE SYNDROMES

  1974cited by this paper
• Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography.

  1974cited by this paper
• Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid

  1973cited by this paper
• Stimulation and destruction of the locus coeruleus: opposite effects on 3-methoxy-4-hydroxyphenylglycol sulfate levels in the rat cerebral cortex.

  1973cited by this paper
• Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders.

  1973cited by this paper
• Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness.

  1973cited by this paper
• Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

  1972cited by this paper
• Cerebrospinal Fluid Levels of MHPG in Affective Disorders

  1972cited by this paper
• Indoleamines and affective disorders.

  1972cited by this paper
• Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.

  1972cited by this paper
• Catecholamines and mania: The effect of alpha‐methyl‐para‐tyrosine on manic behavior and catecholamine metabolism

  1971cited by this paper
• Origin of 5-Hydroxyindoleacetic Acid in the Spinal Fluid

  1971cited by this paper
• Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex.

  1971cited by this paper
• Regular Induction of Hypomania by L-Dopa in “Bipolar” Manic-depressive Patients

  1971cited by this paper
• Biogenic Amines and Emotion

  1967cited by this paper
• 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

  1966cited by this paper
• The catecholamine hypothesis of affective disorders: a review of supporting evidence.

  1965cited by this paper
• Norepinephrine in depressive reactions. A review.

  1965cited by this paper
• An Analysis of Variance Test for Normality (Complete Samples)

  1965cited by this paper

• Bipolar Affective Disorder and Clinical Depression: Comparative Analysis of the Serotonergic System Role in Pathogenesis and Correction

  2025cites this paper
• Doxycycline reversal of amphetamine-induced mania-like behavior is related to adjusting brain monoamine abnormalities and antioxidant effects in primary hippocampal neurons

  2024cites this paper
• A novel murine model of mania

  2023cites this paper
• Glial-Neuronal Interaction in Synapses: A Possible Mechanism of the Pathophysiology of Bipolar Disorder.

  2023cites this paper
• Association between genetic variants of the norepinephrine transporter gene (SLC6A2) and bipolar I disorder.

  2020cites this paper
• Features of mood associated with high body weight in females with fibromyalgia.

  2018cites this paper
• Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series

  2018cites this paper
• Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series

  2018cites this paper
• Dissociable effects of systemic and orbitofrontal administration of adrenoceptor antagonists on yohimbine‐induced motor impulsivity

  2017cites this paper
• Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls

  2017cites this paper
• Type 2 diabetes mellitus, drug addiction, bipolar disorder and epilepsy display overlapping aetiopathogenic mechanisms: Implication for prevention and pharmacotherapy

  2015cites this paper
• A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

  2015cites this paper
• Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration

  2015cites this paper
• Is elevated norepinephrine an etiological factor in some cases of schizophrenia?

  2014cites this paper
• Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view

  2014cites this paper
• Implication de la protéine kinase C dans les troubles bipolaires : vers de nouvelles cibles thérapeutiques

  2013cites this paper
• Chronic lithium treatment influences impulse control and cognition and regulates gene expression

  2013influential citation
• AB1096 Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder

  2012cites this paper
• Serotonergic Dysfunction in Patients with Bipolar Disorder Assessed by the Loudness Dependence of the Auditory Evoked Potential

  2012cites this paper
• The Association of Bipolar Spectrum Disorders and Borderline Personality Disorder

  2012cites this paper
• The role of the aminergic systems in the pathophysiology of bipolar disorder.

  2011cites this paper
• Behavioral neurobiology of bipolar disorder and its treatment

  2011cites this paper
• Neurotransmitter Systems in Bipolar Disorder

  2010cites this paper
• Inflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases

  2009cites this paper
• Biomarkers for Psychiatric Disorders

  2009cites this paper
• Understanding the neurobiology of bipolar depression

  2009cites this paper
• Metabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders

  2008cites this paper
• Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder

  2008cites this paper
• San-Yuan Huang Æ Ming-Teng Lin Æ Mee-Jen Shy Æ Wei-Wen Lin Æ Fang-Yi Lin Æ Ru-Band Lu Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder

  2008cites this paper
• Association study of the norepinephrine transporter gene polymorphisms and bipolar disorder in Han Chinese population

  2007cites this paper
• Receptores 5HT2 y lugares de unión DE 3H-imipramina Y 3H-paroxetina en membrana de plaqueta en trastorno bipolar.

  2007cites this paper
• Serotonergic Dysfunction in Mood Disorders

  2007cites this paper
• A quantitative trait locus for variation in dopamine metabolism mapped in a primate model using reference sequences from related species

  2007cites this paper
• Major affective disorders and schizophrenia: a common molecular signature?

  2006cites this paper
• Bipolar mania and plasma amino acids: increased levels of glycine.

  2006cites this paper
• Effect of risperidone on plasma catecholamine metabolites and brain‐derived neurotrophic factor in patients with bipolar disorders

  2006cites this paper
• Two Cases of Bipolar Disorder Successfully Stabilized for Five Years with a Low Dose of Risperidone and Lithium

  2006cites this paper
• Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.

  2006cites this paper
• PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.

  2002cites this paper
• Cerebrospinal fluid and behavioral changes after methyltestosterone administration: preliminary findings.

  2001cites this paper
• Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects.

  2001cites this paper
• Serotonin and bipolar disorder.

  2001cites this paper
• Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors.

  2000cites this paper
• Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies.

  2000cites this paper
• A neural network model of personality

  1999cites this paper
• Clonidine Does Not Potentiate the Antipsychotic Effects of Neuroleptics in Chronically Ill Patients

  1998cites this paper
• Pretreatment plasma HVA predicts neuroleptic response in manic psychosis.

  1998cites this paper
• Apomorphine induced alteration in corneofundal potentials in depression.

  1997cites this paper
• Pupillary changes associated with the development of stimulant-induced mania: a case report.

  1997cites this paper
• Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations.

  1997cites this paper
• Bipolar mood disorders in the elderly.

  1997cites this paper
• Mean genes and the biology of aggression: a critical review of recent animal and human research.

  1996cites this paper
• Clonidine monotherapy of a patient with mixed bipolar disorder and mania: Changes in symptomatology and neurochemical variables

  1995cites this paper
• Catecholamines in depression: an update.

  1994cites this paper
• CSF and plasma MHPG, and CSF MHPG index: pretreatment levels in diagnostic groups and response to somatic treatments.

  1994cites this paper
• Biology of Bipolar Disorder

  1993cites this paper
• Mania in late life: focus on age at onset.

  1992cites this paper
• Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.

  1992cites this paper
• Mania: sympathoadrenal function and clinical state.

  1991cites this paper
• Psychiatric applications of bromocriptine therapy.

  1990cites this paper
• The effect of oral salbutamol on cation transport measured in vivo in healthy volunteers.

  1990cites this paper
• Plasma 3‐methoxy‐4‐hydroxyphenylglycol in manic patients: relationships with clinical variables

  1990cites this paper
• Influence of gonadal steroids on human and monkey cerebrospinal fluid homovanillic acid concentrations.

  1989cites this paper
• Hallucinations and delusions in 1,715 patients with unipolar and bipolar affective disorders.

  1989cites this paper
• Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

  1989cites this paper
• CSF biochemical correlates of mixed affective states

  1988cites this paper
• Premenstrual relapse of puerperal psychosis.

  1988cites this paper
• Clinical and biochemical correlates of bradyphrenia in Parkinson's disease

  1987cites this paper
• Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome.

  1987cites this paper
• Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.

  1986cites this paper
• Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome.

  1986cites this paper
• Effects of Lithium on Brain Metabolism

  1986cites this paper
• Biochemistry of Mania

  1985cites this paper
• Lithium therapy for mania and depression.

  1985cites this paper
• Plasma Cortisol Levels in Mania: Associated Clinical Ratings and Changes during Treatment with Haloperidol

  1985cites this paper
• Influenza and mania: a possible connection with the locus ceruleus.

  1985cites this paper
• Cerebrospinal Fluid Amine Metabolite Studies in Depression: Research Update

  1985cites this paper
• The neuroendocrinology of mania.

  1985cites this paper
• Three cases of manic symptoms following yohimbine administration.

  1984cites this paper
• Genetic factors in affective illness.

  1984cites this paper
• The Emerging Neurobiology of Mood Disorder

  1984cites this paper
• Positron emission tomographic study of affective disorders: Problems and strategies

  1984cites this paper
• Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism.

  1984cites this paper
• CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls.

  1984cites this paper
• CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.

  1983cites this paper